Latest news
Purple Biotech Releases Q2 2026 Financial Results - AlphaStreetAlphaStreet · Fri, 07 Aug 2026 23:22:36 GMTPPBT Maintained by HC Wainwright & Co. -- Price Target Lowered t - GuruFocusGuruFocus · Fri, 07 Aug 2026 19:08:29 GMTPurple Biotech Ltd (PPBT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 14:18:18 GMTPurple Biotech Reports Second Quarter 2026 Financial Results - TradingViewTradingView · Fri, 07 Aug 2026 13:04:10 GMTPurple Biotech (NASDAQ: PPBT) posts Q2 2026 profit on warrant revaluation - Stock TitanStock Titan · Fri, 07 Aug 2026 11:03:56 GMTPurple Biotech's IM1240 Shows ~8-Fold Longer Half-Life in Preclinical Data - Stock TitanStock Titan · Fri, 07 Aug 2026 11:00:00 GMTPPBT 6-K & SEC Filings - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 07:00:00 GMTPPBT Q1 2025 Earnings: Reported Loss of $0.17 Per Share Amid Ongoing Clinical Development - Earnings Acceleration Picks - dars.gov.etdars.gov.et · Sun, 02 Aug 2026 22:35:31 GMT